Company news: GlaxoSmithKline

Share this article:
GlaxoSmithKline is readying another round of R&D cuts and giving its Research Triangle Park workforce a haircut, with plans to eliminate positions at its Neurosciences Medicine Development Center, according to the News & Observer of Raleigh, NC. Less than 50 R&D jobs are being eliminated nationwide, with fewer than half of those coming from Research Triangle Park and Philadelphia emerging largely unscathed. It's a drop in the bucket after years of deep cuts at the company, which has cut 22,000 jobs worldwide between 2007 and 2010, the newspaper reported.
Share this article:

Email Newsletters

More in Business Briefs

Payment database confounds doctors

ProPublica reports that doctors are struggling with a time-intensive registration process and are getting an error message that CMS says is not an error message.

Gilead's idelalisib hat trick

The FDA greenlighted the drug for three cancers.

Shire expands rare disease reach

A $225-million deal with US biotech ArmaGen gives Shire worldwide commercialization rights to an experimental enzyme replacement therapy.